Medication info
Rabiet 20 mg Tablets (Rabeprazole Sodium)

Rabiet 20 mg Tablets (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
KS Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablets
Packaging
28 tablets/PTP[(14 tablets/PTP*2)]
Approval status
Active

MFDS item code 202000217 · Approved 2020.01.14 · Insurance code 059000510

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcers, duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose is divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Since hepatic function is often reduced, administer with caution.
Child dose
○ Children Safety in children has not been established.

Ingredients

Manufacturer
KS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers and is used to alleviate symptoms of erosive and ulcerative gastroesophageal reflux disease and for long-term maintenance therapy. It is also used in combination with antibiotics to treat gastrointestinal ulcer patients infected with Helicobacter pylori and aids in conditions associated with excessive gastric acid secretion such as Zollinger-Ellison syndrome. This medication regulates gastric acid secretion to protect the gastric mucosa and improve symptoms.

How to take

Adult dose

Gastric ulcers, duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose is divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Since hepatic function is often reduced, administer with caution.

Child dose

○ Children Safety in children has not been established.

Precautions

This medication should not be used in patients with allergies or hypersensitivity reactions to specific components or to the benzimidazole class. It is also not safe for patients allergic to penicillin or macrolide antibiotics, those taking certain heart-related medications, patients receiving atazanavir or rilpivirine, and women who are pregnant or breastfeeding. Patients with impaired liver function, elderly patients, those with a history of drug allergies, and patients allergic to the yellow No. 4 (tartrazine) dye contained in this medication should use it with caution. This medication may cause allergic reactions such as skin rashes, itching, and hives, so usage should be immediately discontinued in the presence of such symptoms. Changes in blood cell counts or liver function abnormalities, as well as cardiovascular symptoms, may occur, requiring regular blood tests and liver function tests. Gastrointestinal symptoms can include diarrhea, abdominal pain, nausea, and vomiting, and in rare cases, serious conditions such as hepatitis or pancreatitis may occur. Neurological symptoms such as headache, insomnia, and dizziness have been reported, and in rare cases, confusion or seizures can occur, requiring caution. Respiratory symptoms such as coughing and dyspnea may occur, and in rare cases, serious lung diseases may develop, so any unusual symptoms should be promptly discussed with a healthcare professional. Muscle pain, joint pain, skin rashes, hair loss, and severe skin reactions may occur, necessitating immediate discontinuation of use and consultation with a doctor if such symptoms arise. Ocular symptoms such as blurred vision and eye pain have been reported, so notify a healthcare professional if there are changes in vision. Renal function abnormalities or symptoms such as difficulty urinating and hematuria may occur, requiring monitoring of kidney health. Long-term use may increase the risk of osteoporosis and fractures, so patients on long-term treatment need bone density management. Hypomagnesemia may occur, so patients using it for a long time or in combination with certain medications should regularly check their blood magnesium levels. This medication strongly suppresses gastric acid secretion, slightly increasing the risk of bacterial infections in the stomach, and persistent chronic diarrhea may raise suspicion of Clostridium difficile infection. Caution is advised as drowsiness may occur while driving or operating machinery. There may be interactions with other medications, so consult a physician, especially when used in combination with warfarin, methotrexate, antibiotics, or antifungals. Women who are pregnant or breastfeeding should not use this medication, and elderly patients should use it cautiously due to increased risk of side effects from impaired liver function. Safety in children has not been established, so it is best not to use it in this population. This medication should not be chewed or crushed and must be swallowed whole, and it should be stored in a safe place out of reach of children. In case of overdose, there are no specific antidotes, so treatment should be symptomatic and done according to medical advice.

Side effects

Rash, hives, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypopigmented anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina pectoris, atrioventricular block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neuropathic sensitivity, drowsiness, lightheadedness, depression, agitation, amnesia, confusion, extrapyramidal syndrome, volume overload, upper and lower limb flaccidity, tactile impairment, decreased grip strength, language confusion, staggering, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, hypertonic muscle disorder, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary difficulty, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, heavy menstruation, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, visual impairment, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is best stored at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablets

Package unit

28 tablets/PTP[(14 tablets/PTP*2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.